Target intelligence / Profile preview

Inward rectifier potassium channel 4 (Kir2.3) (Kir2.3)

Target
Kir2.3
Molecular classification
Ion channel, Inwardly rectifying potassium channel
01

Overview

The Inward rectifier potassium channel 4 (Kir2.3), encoded by the KCNJ4 gene, is a member of the inwardly rectifying potassium channel family that plays a vital role in stabilizing the resting membrane potential (UniProt: P48050). These channels preferentially allow potassium ions to flow into the cell, thereby controlling the excitability of neurons and cardiomyocytes (NCBI Gene: 3761). Kir2.3 is predominantly expressed in the central nervous system, specifically within the hippocampus and forebrain, where it often associates with PDZ-domain proteins to modulate synaptic transmission (PubMed: 10433262). In the heart, Kir2.3 contributes to the IK1 current, which is essential for the terminal repolarization phase of the action potential (PubMed: 11886830). Dysfunction of Kir2.3 has been linked to various pathological states, including cardiac arrhythmias and potential roles in neuropsychiatric conditions (PubMed: 25833132). While it is a recognized therapeutic target, the development of highly selective ligands remains a challenge in pharmacology, with current interactions limited to non-specific blockers like barium or multi-channel antiarrhythmics like flecainide (PubChem: CID 3356).

Other names
KCNJ4HIRHIRK2IRK3HRK1Potassium inwardly rectifying channel subfamily J member 4
02

Mechanism of action

Inhibition of potassium efflux through the channel pore to modulate membrane potential and action potential duration.

03

Biological functions

Potassium ion transportMaintenance of resting membrane potentialRegulation of neuronal excitabilityCardiac repolarization
04

Disease associations

Cardiovascular diseaseArrhythmiaNeurological disease
05

Safety considerations

Pro-arrhythmic effectsPotential for long QT syndromeNeurological side effects due to high CNS expressionElectrolyte imbalance
06

Interacting drugs

Barium

6 more in the full profile.

07

Biomarkers

KCNJ4 mRNA expression levelsKCNJ4 protein expressionElectrocardiogram (ECG) QT interval duration

Beyond the preview

Go deeper on Inward rectifier potassium channel 4 (Kir2.3) (Kir2.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inward rectifier potassium channel 4 (Kir2.3) (Kir2.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call